Search

everythinglearnresearchcommunity

for

Search:↓

PRP use in skin care and plastic surgery is growing, especially in the U.S. and Italy.

Nanotechnology could improve hair regrowth but faces challenges like complexity and safety concerns.

Nanotechnology shows promise for better hair loss treatments but needs more research for safety and effectiveness.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

The conclusion is that there's a link between high testosterone levels, insulin resistance, and certain skin conditions, regardless of obesity.

Different species and human skin models vary in their skin enzyme activities, with pig skin and some models closely matching human skin, useful for safety assessments and understanding the skin's protective roles.

Risk analysis is important for safely adjusting pharmaceutical formulas while maintaining their quality and effectiveness.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

Some people with pattern hair loss may also have scalp inflammation and scarring similar to lichen planopilaris.

Lymphocytes, especially CD8+ T cells, play a key role in causing alopecia areata, and targeting them may lead to new treatments.

The study concluded that severity of Frontal fibrosing alopecia is not linked to how long someone has it, can start before menopause, and eyebrow loss may be an early sign.

Stress hormones like cortisol may trigger psoriasis flare-ups.

Topical metformin helped regrow hair in two women with a hard-to-treat scarring hair loss condition.

Topical vitamin D is useful for some skin conditions but not effective for others, and more research is needed.

A patient with total hair loss developed vitiligo after using a treatment called DCP.

Baricitinib successfully treated severe hair loss.

Both treatments helped hair regrowth in alopecia areata, with isopropanol being better tolerated.

Minoxidil treats hair loss, promotes growth, has side effects, and has recent patents.

The new clobetasol propionate foam is effective and safe for treating alopecia areata.

A new method accurately measures clobetasol propionate in hair and skin.

TrichoFoam™ is a stable option for personalized hair loss treatment with most ingredients remaining effective for 90-180 days.

Combining low-level laser therapy with scalp microneedling and a clobetasol solution significantly improves androgenetic alopecia.

Topical clobetasol propionate 0.05% ointment is more effective in promoting hair regrowth in patients with alopecia areata than topical tacrolimus 0.1% ointment.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

The combined therapy was effective and safe for children with severe alopecia areata.

Individualized treatment plans are crucial for children with alopecia areata, with promising options like JAK inhibitors showing significant hair regrowth.

Two elderly men developed scalp inflammation after using a gel for skin lesions, which healed with treatment except for some permanent hair loss.

A woman developed swelling in her body after taking low-dose oral minoxidil for hair loss, but it resolved after stopping the medication.

EPDS and MS might share an immune-related cause.